1-deoxynojirimycin has been researched along with Hyperglycemia in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 17 (68.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, I; Hayashi, E; Hirono, S; Imahori, T; Kato, A; Koseki, J; Miyauchi, S; Nakagome, I; Nash, RJ; Natori, Y; Shimaoka, H; Takahata, H; Yoshimura, Y | 1 |
| Davis, SN; Hedrington, MS | 1 |
| Anno, T; Hashiramoto, M; Hirukawa, H; Kaku, K; Kanda-Kimura, Y; Kawasaki, F; Kimura, T; Matsuki, M; Mune, T; Shimoda, M; Tatsumi, F; Tawaramoto, K | 1 |
| Chiku, M; Fukamachi, D; Hirayama, A; Hiro, T; Kitano, D; Li, Y; Okumura, Y; Saito, S; Takayama, T | 1 |
| Goda, T; Harazaki, T; Imai, C; Inoue, S; Mochizuki, K | 2 |
| Kim, SS; Koide, M; Nagasawa, Y; Sawada, T; Shiotani, H; Terashita, D; Yokoyama, M | 1 |
| Chang, Q; Fan, LQ; Guo, SR; Kong, LT; Wang, Q; Xiao, BX | 1 |
| Hanaoka, H; Hashimoto, N; Ishikawa, K; Kanatsuka, A; Kobayashi, K; Kuribayashi, N; Onishi, S; Sakurai, K; Sato, Y; Takemoto, M; Terano, T; Uchida, D; Yokoh, H; Yokote, K | 1 |
| Fukaya, N; Goda, T; Mochizuki, K; Shimada, M; Tanaka, Y | 2 |
| Babu, RK; Deshpande, MC; Trivedi, RK; Venkateswarlu, V | 1 |
| Abiko, A; Araki, S; Haneda, M; Itoh, H; Koya, D; Maegawa, H; Nakagawa, A; Nishizawa, M; Uzu, T; Yokomaku, Y; Yokoyama, H | 1 |
| Morimoto, A; Nishimura, R; Tajima, N; Taki, K; Tsujino, D; Utsunomiya, K | 1 |
| Hamaguchi, T; Katsuno, T; Konishi, K; Kusunoki, Y; Miuchi, M; Miyagawa, J; Murai, K; Nagai, E; Namba, M; Ochi, F; Tokuda, M | 1 |
| Cho, JK; Curtis-Long, MJ; Jung, S; Kim, YS; Lee, BW; Park, KH; Ryu, HW; Yuk, HJ | 1 |
| Fleet, GW; Kato, A; Nash, RJ; Yu, CY | 1 |
| Kishimoto, M; Noda, M | 1 |
| Schnell, O; Standl, E | 1 |
| Miyahara, C; Miyazawa, M; Mizusaki, S; Sakai, A; Satoh, S | 1 |
| Baliga, VP; Jayaram, S; Kinagi, S; Mishra, AB; Periyandavar, I; Rajadhyaksha, GC; Sharma, A; Singh, KP | 1 |
| Tattersall, R | 1 |
| Mooradian, AD; Thurman, JE | 1 |
| Aoyagi, Y; Enomoto, H; Ezure, Y; Yoshikuni, Y | 1 |
| Cañizo, JF; Hillebrand, I; Navascués, I; Sabán, J; Serrano-Rios, M | 1 |
5 review(s) available for 1-deoxynojirimycin and Hyperglycemia
| Article | Year |
|---|---|
Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes.
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Metformin; Prediabetic State | 2019 |
Iminosugars as therapeutic agents: recent advances and promising trends.
Topics: 1-Deoxynojirimycin; Antiviral Agents; Gaucher Disease; Glycoside Hydrolases; Humans; Hyperglycemia; Imino Sugars; Molecular Chaperones; Virus Diseases | 2011 |
Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluation.
Topics: 1-Deoxynojirimycin; Acarbose; Cardiovascular Diseases; Diabetes Complications; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol | 2012 |
Alpha-glucosidase inhibition as an adjunct to the treatment of type 1 diabetes.
Topics: 1-Deoxynojirimycin; Acarbose; Blood Glucose; Diabetes Mellitus, Type 1; Eating; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Imino Pyranoses; Trisaccharides | 1993 |
Drug therapy of postprandial hyperglycaemia.
Topics: 1-Deoxynojirimycin; Acarbose; Amyloid; Carbamates; Diabetes Mellitus; Enzyme Inhibitors; Glucosamine; Glyburide; Humans; Hyperglycemia; Hypoglycemic Agents; Imino Pyranoses; Inositol; Insulin; Insulin Lispro; Islet Amyloid Polypeptide; Piperidines; Postprandial Period; Trisaccharides | 1999 |
8 trial(s) available for 1-deoxynojirimycin and Hyperglycemia
| Article | Year |
|---|---|
Concomitant use of miglitol and mitiglinide as initial combination therapy in type 2 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Isoindoles; Male; Metformin; Middle Aged; Prognosis | 2013 |
Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemia.
Topics: 1-Deoxynojirimycin; Acute Coronary Syndrome; Aged; Case-Control Studies; Endothelium, Vascular; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Manometry; Middle Aged; Percutaneous Coronary Intervention; Postprandial Period; Treatment Outcome | 2013 |
Comparison of effects of α-Glucosidase inhibitors and glinide drugs on endothelial dysfunction in diabetic patients with coronary artery disease.
Topics: 1-Deoxynojirimycin; Aged; Aged, 80 and over; Coronary Artery Disease; Cyclohexanes; Diabetic Angiopathies; Dyslipidemias; Endothelium, Vascular; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Middle Aged; Nateglinide; Phenylalanine | 2014 |
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label, non-i
Topics: 1-Deoxynojirimycin; Aged; alpha-Glucosidases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Gastrointestinal Agents; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Inositol; Japan; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Triazoles | 2014 |
Comparing the efficacy of α-glucosidase inhibitors in suppressing postprandial hyperglycemia using continuous glucose monitoring: a pilot study-the MAJOR study.
Topics: 1-Deoxynojirimycin; Acarbose; Adult; Aged; alpha-Glucosidases; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Japan; Male; Middle Aged; Pilot Projects; Young Adult | 2011 |
Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adult; Aged; Deoxyglucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Serum Albumin; Weight Loss; Young Adult | 2011 |
Evaluation of the efficacy, safety and tolerability of miglitol in adult Indian patients with uncomplicated type 2 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Aged; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Imino Pyranoses; India; Male; Middle Aged; Postprandial Period; Prospective Studies; Risk Factors; Treatment Outcome | 2007 |
Effect of two new alpha-glucosidase inhibitors in insulin-dependent diabetic patients.
Topics: 1-Deoxynojirimycin; Adult; Diabetes Mellitus, Type 1; Diet; Double-Blind Method; Female; Glucosamine; Glucosidases; Humans; Hyperglycemia; Hypoglycemia; Imino Pyranoses; Insulin; Male; Random Allocation | 1988 |
12 other study(ies) available for 1-deoxynojirimycin and Hyperglycemia
| Article | Year |
|---|---|
α-1-C-butyl-1,4-dideoxy-1,4-imino-l-arabinitol as a second-generation iminosugar-based oral α-glucosidase inhibitor for improving postprandial hyperglycemia.
Topics: Administration, Oral; Animals; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Imino Sugars; Inhibitory Concentration 50; Male; Mice; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2012 |
Inhibition of postprandial hyperglycemia by either an insulin-dependent or -independent drug reduces the expression of genes related to inflammation in peripheral leukocytes of OLETF rats.
Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Animals; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Gene Expression; Hyperglycemia; Hypoglycemic Agents; Inflammation; Insulin; Interleukin-18; Interleukin-1beta; Leukocytes, Mononuclear; Male; Pyrimidines; Rats; Rats, Inbred OLETF; Receptors, Interleukin-1; S100 Proteins; Sucrose; TNF Receptor-Associated Factor 2 | 2013 |
Pharmacokinetic mechanism of enhancement by Radix Pueraria flavonoids on the hyperglycemic effects of Cortex Mori extract in rats.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Flavonoids; Hyperglycemia; Intestinal Absorption; Intestine, Small; Male; Morus; Plant Extracts; Plant Roots; Pueraria; Rats; Rats, Sprague-Dawley | 2014 |
Treatment with DPP-4I Anagliptin or α-GI Miglitol Reduces IGT Development and the Expression of CVD Risk Factors in OLETF Rats.
Topics: 1-Deoxynojirimycin; Animals; Aorta; Blood Glucose; Cardiovascular Diseases; Cell Adhesion Molecules; Cytokines; Fasting; Hyperglycemia; Hypoglycemic Agents; Interleukin-1beta; Leukocytes; Male; Postprandial Period; Pyrimidines; Rats; Rats, Inbred OLETF; Risk Factors; S100 Proteins; Tumor Necrosis Factor-alpha | 2015 |
The alpha-glucosidase inhibitor miglitol suppresses postprandial hyperglycaemia and interleukin-1beta and tumour necrosis factor-alpha gene expression in rat peripheral leucocytes induced by intermittent sucrose loading.
Topics: 1-Deoxynojirimycin; Animals; Diabetes Mellitus, Experimental; Dietary Sucrose; Gene Expression; Glycoside Hydrolase Inhibitors; Hyperglycemia; Interleukin-1beta; Leukocytes, Mononuclear; Male; Models, Animal; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Sweetening Agents; Tumor Necrosis Factor-alpha | 2009 |
Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels.
Topics: 1-Deoxynojirimycin; Administration, Oral; Animals; Blood Glucose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Hyperglycemia; Hypoglycemic Agents; Intestine, Small; Male; Random Allocation; Rats; Rats, Sprague-Dawley | 2009 |
Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol.
Topics: 1-Deoxynojirimycin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Interleukin-18; Postprandial Period | 2011 |
Reduced expression of β2 integrin genes in rat peripheral leukocytes by inhibiting postprandial hyperglycemia.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; CD18 Antigens; Disaccharidases; Enzyme Inhibitors; Gene Expression Regulation; Glycoside Hydrolase Inhibitors; Hyperglycemia; Intestine, Small; Leukocytes; Male; Microvilli; Rats; Rats, Sprague-Dawley | 2010 |
α-Glucosidase inhibition and antihyperglycemic activity of prenylated xanthones from Garcinia mangostana.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Disease Models, Animal; Enzyme Inhibitors; Fruit; Garcinia mangostana; Glycoside Hydrolase Inhibitors; Hyperglycemia; Hypoglycemic Agents; Inhibitory Concentration 50; Male; Maltose; Phytotherapy; Plant Extracts; Postprandial Period; Rats; Rats, Sprague-Dawley; Seeds; Xanthones | 2011 |
A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markers.
Topics: 1-Deoxynojirimycin; Aged; Biomarkers; Blood Glucose; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Monitoring, Physiologic; Pilot Projects; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2011 |
Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats.
Topics: 1-Deoxynojirimycin; Animals; Dietary Carbohydrates; Dietary Sucrose; Disaccharidases; Enzyme Inhibitors; Food; Glycoside Hydrolase Inhibitors; Hyperglycemia; Intestine, Small; Maltose; Morus; Oligo-1,6-Glucosidase; Plant Extracts; Plant Leaves; Rats; Rats, Wistar; Starch; Sucrase | 2004 |
Inhibition of intestinal alpha-glucosidase and postprandial hyperglycemia by N-substituted moranoline derivatives.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Food; Glucosamine; Glycoside Hydrolase Inhibitors; Hyperglycemia; Intestines; Rabbits; Structure-Activity Relationship | 1988 |